Pfizer said the booster triggered more antibodies against omicron BQ.1.1, BA.4.6, BA.2.75.2 and XBB.1 in adults older than 55 compared to the original vaccines.
Moderna found that the new booster triggered five times more antibodies against omicron BA.5 than the old vaccines in people with prior Covid infections.
){kind=link}
){kind=link}